Clinical outcome of oropharyngeal carcinoma treated with platinum-based chemoradiotherapy

Oral Oncology

Volumn 45, Issue 9, 2009, Pages 830-834

  Nakamura, Tatsuya ^a   Kodaira, Takeshi ^a   Tachibana, Hiroyuki ^a   Tomita, Natsuo ^a   Yokouchi, Jun ichi ^a   Fuwa, Nobukazu ^a  

^a Southern Tohoku General Hospital   (Japan)

Author keywords

Chemoradiotherapy; Clinical outcome; Oropharyngeal carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; NEDAPLATIN; SODIUM THIOSULFATE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG TOLERABILITY; ESOPHAGUS METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; HYPOPHARYNX CANCER; JAW OSTEONECROSIS; LARYNX EDEMA; LEUKOPENIA; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NECK CANCER; NEUTROPENIA; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SALVAGE THERAPY; TONGUE CANCER; TONGUE CARCINOMA; TRACHEOSTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 68949204293     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.01.014     Document Type: Article

References (40)

1. Lauciello F.R., Vergo T., Schaaf N.G., and Zimmerman R. Prosthodontic and speech rehabilitation after partial and complete glossectomy. J Prosthet Dent 43 2 (1980) 204-211
2. Pauloski B.R., Rademaker A.W., Logemann J.A., Stein D., Beery Q., Newman L., et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck 22 5 (2000) 474-482
3. Tupchong L., Scott C.B., Blitzer P.H., Marcial V.A., Lowry L.D., Jacobs J.R., et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 20 1 (1991) 21-28
4. Pauloski B.R., Logemann J.A., Colangelo L.A., Rademaker A.W., McConnel F.M., Heiser M.A., et al. Surgical variables affecting speech in treated patients with oral and oropharyngeal cancer. Laryngoscope 108 6 (1998) 908-916
5. Nguyen N.P., and Sallah S. Combined chemotherapy and radiation in the treatment of locally advanced head and neck cancers. In Vivo 14 1 (2000) 35-39
6. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 9208 (2000) 949-955
7. Forastiere A.A., Goepfert H., Maor M., Pajak T.F., Weber R., Morrison W., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 22 (2003) 2091-2098
8. Nguyen N.P., Sallah S., Karlsson U., and Antoine J.E. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer 94 4 (2002) 1131-1141
9. Fuwa N., Kodaira T., Furutani K., Tachibana H., Nakamura T., Nakahara R., et al. Arterial chemoradiotherapy for locally advanced tongue cancer: analysis of retrospective study of therapeutic results in 88 patients. Int J Radiat Oncol Biol Phys 72 4 (2008) 1090-1100
10. Robbins K.T., Kumar P., Wong F.S., Hartsell W.F., Flick P., Palmer R., et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 22 7 (2000) 687-693
11. Robbins K.T., Storniolo A.M., Kerber C., Vicario D., Seagren S., Shea M., et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 12 10 (1994) 2113-2120
12. Pauloski B.R., Rademaker A.W., Logemann J.A., McConnel F.M., Heiser M.A., Cardinale S., et al. Surgical variables affecting swallowing in patients treated for oral/oropharyngeal cancer. Head Neck 26 7 (2004) 625-636
13. Pauloski B.R., and Logemann J.A. Impact of tongue base and posterior pharyngeal wall biomechanics on pharyngeal clearance in irradiated postsurgical oral and oropharyngeal cancer patients. Head Neck 22 2 (2000) 120-131
14. Dropkin M.J. Body image and quality of life after head and neck cancer surgery. Cancer Pract 7 6 (1999) 309-313
15. Denittis A.S., Machtay M., Rosenthal D.I., Sanfilippo N.J., Lee J.H., Goldfeder S., et al. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment. Am J Otolaryngol 22 5 (2001) 329-335
16. Lawrence T.S., Blackstock A.W., and McGinn C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13 1 (2003) 13-21
17. Calais G., Alfonsi M., Bardet E., Sire C., Germain T., Bergerot P., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 24 (1999) 2081-2086
18. Olmi P., Crispino S., Fallai C., Torri V., Rossi F., Bolner A., et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy - a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 1 (2003) 78-92
19. Machtay M., Rosenthal D.I., Hershock D., Jones H., Williamson S., Greenberg M.J., et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol 20 19 (2002) 3964-3971
20. Adelstein D.J., Saxton J.P., Lavertu P., Rybicki L.A., Esclamado R.M., Wood B.G., et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 20 5 (2002) 1405-1410
21. Kies M.S., Bennett C.L., and Vokes E.E. Locally advanced head and neck cancer. Curr Treat Options Oncol 2 1 (2001) 7-13
22. Vokes E.E., and Pajak T.F. Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer. Ann Oncol 9 5 (1998) 471-473
23. Fu K.K., Pajak T.F., Trotti A., Jones C.U., Spencer S.A., Phillips T.L., et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 1 (2000) 7-16
24. Ang K.K., Harris J., Garden A.S., Trotti A., Jones C.U., Carrascosa L., et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J Clin Oncol 23 13 (2005) 3008-3015
25. Adelstein D.J., Li Y., Adams G.L., Wagner Jr. H., Kish J.A., Ensley J.F., et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21 1 (2003) 92-98
26. Chao K.S. Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer. Semin Radiat Oncol 12 Suppl. 1 (2002) 20-25
27. Chao K.S., Majhail N., Huang C.J., Simpson J.R., Perez C.A., Haughey B., et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 61 3 (2001) 275-280
28. Eisbruch A., Ship J.A., Dawson L.A., Kim H.M., Bradford C.R., Terrell J.E., et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 27 7 (2003) 832-837
29. Leibel S.A., Fuks Z., Zelefsky M.J., Wolden S.L., Rosenzweig K.E., Alektiar K.M., et al. Intensity-modulated radiotherapy. Cancer J 8 2 (2002) 164-176
30. Gregoire V., and Maingon P. Intensity-modulated radiation therapy in head and neck squamous cell carcinoma: an adaptation of 2-dimensional concepts or a reconsideration of current clinical practice. Semin Radiat Oncol 14 2 (2004) 110-120
31. Xia P., Fu K.K., Wong G.W., Akazawa C., and Verhey L.J. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48 2 (2000) 329-337
32. Chao K.S., Low D.A., Perez C.A., and Purdy J.A. Intensity-modulated radiation therapy in head and neck cancers: the Mallinckrodt experience. Int J Cancer 90 2 (2000) 92-103
33. Eisbruch A., Dawson L.A., Kim H.M., Bradford C.R., Terrell J.E., Chepeha D.B., et al. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg 53 3 (1999) 271-275
34. Lee N., Xia P., Quivey J.M., Sultanem K., Poon I., Akazawa C., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 1 (2002) 12-22
35. Pacholke H.D., Amdur R.J., Morris C.G., Li J.G., Dempsey J.F., Hinerman R.W., et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol 28 4 (2005) 351-358
36. Chao K.S., Ozyigit G., Blanco A.I., Thorstad W.L., Deasy J.O., Haughey B.H., et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 59 1 (2004) 43-50
37. de Arruda F.F., Puri D.R., Zhung J., Narayana A., Wolden S., Hunt M., et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64 2 (2006) 363-373
38. Eisbruch A., Marsh L.H., Dawson L.A., Bradford C.R., Teknos T.N., Chepeha D.B., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59 1 (2004) 28-42
39. Posner M.R., Hershock D.M., Blajman C.R., Mickiewicz E., Winquist E., Gorbounova V., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 17 (2007) 1705-1715
40. Vermorken J.B., Remenar E., van Herpen C., Gorlia T., Mesia R., Degardin M., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 17 (2007) 1695-1704